2-辛基氰基丙烯酸酯网状敷料用于全关节置换术:敷料设计影响伤口并发症风险
一项18周回顾性研究纳入207例全髋和212例全膝关节置换术,比较两种2-辛基氰基丙烯酸酯液体黏合剂加网状贴片设计。Mesh A(274例)加速剂在网片上,Mesh B(145例)加速剂在涂布器中。Mesh A的伤口并发症、早期假体周围关节感染和90天再手术率均显著低于Mesh B。
要点
- Mesh A组伤口并发症3.2% vs Mesh B组7.6%(P=.049),Mesh A较低。
- Mesh A组早期假体周围关节感染0% vs Mesh B组2.8%(P=.006),Mesh A较低。
- Mesh A组90天伤口并发症再手术0.4% vs Mesh B组3.4%(P=.011),Mesh A较低。
核心结论
- 两种敷料设计在伤口并发症、早期术后假体周围关节感染和90天再手术方面观察到显著不同的表现。
- 加速剂置于涂布器而非网片上可能导致在适当粘合网片形成所需伤口闭合和密封之前发生过早聚合。
研究设计与样本
- 18周回顾性研究,时间为2023年7月至12月。
- 纳入1家机构4名主治医师的207例全髋关节置换术和212例全膝关节置换术病例,使用两种敷料设计之一。
- 两种敷料均为2-辛基氰基丙烯酸酯液体黏合剂配方,局部涂覆于覆盖伤口的聚酯基网片上。
- Mesh A(用于274例)在网片上包含加速剂季铵盐,Mesh B(用于145例)在黏合剂涂布器内包含类似加速剂。
- 证据等级为III级。
主要发现
- 伤口并发症:Mesh A组3.2% vs Mesh B组7.6%(X2=3.86;df=1;P=.049),Mesh B较Mesh A升高。
- 早期假体周围关节感染:Mesh A组0% vs Mesh B组2.8%(X2=7.63;df=1;P=.006),Mesh B较Mesh A升高。
- 90天因伤口并发症再手术:Mesh A组0.4% vs Mesh B组3.4%(X2=6.39;df=1;P=.011),Mesh B较Mesh A升高。
- 浅表手术部位感染:Mesh A组0.7% vs Mesh B组0%(X2=1.06;df=1;P=.302),两组无差异。
- 过敏率:Mesh A组3.3% vs Mesh B组4.1%(X2=0.12;df=1;P=.655),两组无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent liquid adhesive skin closure systems with a mesh patch and a 2-octyl cyanoacrylate liquid formula have shown promising results in total joint arthroplasty. Chemical accelerators are typically included to promote the rapid polymerization of 2-octyl cyanoacrylate. The goal of the study is to distinguish designs and wound complication differences between 2 similar systems. METHODS: An 18-week retrospective study was conducted from July to December 2023, including 207 total hip arthroplasty and 212 total knee arthroplasty cases from 4 attending surgeons at 1 institution that used 1 of 2 dressing designs. Both dressings had a 2-octyl cyanoacrylate liquid adhesive formula that applied topically to a polyester-based mesh overlaying the wound. Mesh A (used in 274 cases) included an accelerator, a quaternary ammonium salt, on the mesh patch, whereas Mesh B (used in 145 cases) included a similar accelerator within the adhesive applicator. RESULTS: Wound complications (3.2 versus 7.6%; X2 = 3.86; df = 1; P = .049), early periprosthetic joint infections (0 versus 2.8%; X2 = 7.63; df = 1; P = .006), and 90-day reoperations for wound complications (0.4 versus 3.4%; X2 = 6.39; df = 1; P = .011) were significantly lower in patients who received Mesh A versus B, respectively. There was no difference in superficial surgical site infections (0.7 versus 0%; X2 = 1.06; df = 1; P = .302) or allergy rates (3.3 versus 4.1%; X2 = 0.12; df = 1; P = .655) between Mesh A and B. CONCLUSIONS: We observed significantly different performance in wound complications, early postoperative periprosthetic joint infections, and 90-day reoperation between the 2 designs. Having the accelerator in the applicator rather than on the mesh patch may lead to premature polymerization before bonding appropriately with the mesh to create the desired wound closure and seal. LEVEL OF EVIDENCE: Level III.
引用
- Woelfle CA, Shah RP, Neuwirth AL, et al. 2-Octyl-Cyanoacrylate Mesh Dressings for Total Joint Arthroplasty: Dressing Design Influences Risks of Wound Complications. J Arthroplasty. 2024. PMID: 38914145. doi:10.1016/j.arth.2024.06.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。